| 参考文献 [1]Gross G,Schofer H,Wassilew S, et al.Herpes zoster guideline of the German Dermatology Society(DDG).Journalof Clinical Virology,2003,26(3):277-289. [2] 徐世正主译.安德鲁斯临床皮肤病学.北京：科学出版社,2004,472-478. [3] Wassilew SW. Brivudin compared with famciclovir in the treatment of herpes zoster: effects in acute disease and chronic pain in immunocompetent patients. A randomized, double-blind, multinational study.J Eur Acad Dermatol Venereol，2005，19(1):47-55. [4]薛志兴,樊碧发.带状疱疹后遗神经痛的诊疗现状.中日友好医院学报,2006,20(3):187-189. [5] Wassilew SW, Wutzler P. Oral brivudin in comparison with acyclovir for herpes zoster: a survey study on postherpetic neuralgia. Antiviral Research, 2003,59(1):57-60. [6] Dworkin RH,White R, O’Connor AB, et al. Healthcare Costs of Acute and Chronic Pain Associated with a Diagnosisof Herpes Zoster.J Am Geriatr Soc，2007,55(8):1168–1175. [7]Lilie HM, Wassilew S.The role of antivirals in the management of neuropathic pain in the older patient with herpes zoster.Drugs Aging，2003，20(8):561-570. [8]Keam SJ, Chapman TM, Figgitt DP.Brivudin (bromovinyl deoxyuridine).Drugs，2004，64(18)：2091-2097.discussion 2098-2099. [9]Andrei G, Snoeck R, Reymen D, et al. Comparative acivity of selected antiviral compounds against clinical isolates of varicela-zoster Virus. Eur J Clin Microbiol Infect Dis，1995,14(4): 318-329. [10]Wassilew SW, Wutzler P. Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients: reaults of a randomized double-blind, multcentered study. Antiviral Research，2003，59(1):49-56. [11]Fyfe JA. Differential phosphorylation of (E)-5-(2-bromovinyl)-2'-deoxyuridine monophosphate by thymidylate kinases from herpes simplex viruses types 1 and 2 and varicella zoster virus.Mol Pharmacol，1982，21(2):432-437. [12]De Clercq E.The antiviral spectrum of (E)-5-(2-bromovinyl)-2'-deoxyuridine.J Antimicrob Chemother，1984，14（Suppl A）:85-95. [13]De Clercq E.(E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU).Med Res Rev，2005，25(1):1-20. [14]Rabasseda X.Brivudine: a herpes virostatic with rapid antiviral activity and once-daily dosing.Drugs Today (Barc)，2003,39(5):359-371. [15]王爱平,漆军,王宏伟,等. 溴夫定治疗带状疱疹的疗效和安全性评价. 中华皮肤科杂志，2007，40（12）：717-719. |
